Stay updated on CYAD-211 Safety, Activity & Kinetics in Myeloma Clinical Trial

Sign up to get notified when there's something new on the CYAD-211 Safety, Activity & Kinetics in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CYAD-211 Safety, Activity & Kinetics in Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-02T12:22:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces NIH’s stated transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It is unrelated to the clinical study details.
    Difference
    0.8%
    Check dated 2026-10-26T11:44:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T12:35:50.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site revision identifier changes from v3.7.0 to v3.7.1, while the displayed study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-12T14:13:45.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study's record history, replacing the previous revision v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-21T22:04:50.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.6) was added to the record history and the previous revision (v3.6.5) was removed, signaling an update to the study record.
    Difference
    0.1%
    Check dated 2026-08-31T16:21:52.000Z thumbnail image

Stay in the know with updates to CYAD-211 Safety, Activity & Kinetics in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CYAD-211 Safety, Activity & Kinetics in Myeloma Clinical Trial page.